3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Bowel Diseases, Inflammatory in 1 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Subbaramaiah, K | 1 |
| Yoshimatsu, K | 1 |
| Scherl, E | 1 |
| Das, KM | 1 |
| Glazier, KD | 1 |
| Golijanin, D | 1 |
| Soslow, RA | 1 |
| Tanabe, T | 1 |
| Naraba, H | 1 |
| Dannenberg, AJ | 1 |
1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1.
Topics: Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Colon; DNA-Binding Protein | 2004 |